Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Other Accumulated Expenses (2023 - 2025)

Akso Health (AHG) has disclosed Other Accumulated Expenses for 2 consecutive years, with $2.0 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Other Accumulated Expenses rose 1709301.71% year-over-year to $2.0 million, compared with a TTM value of $2.0 million through Mar 2024, up 1709301.71%, and an annual FY2024 reading of $2.0 million, up 1709301.71% over the prior year.
  • Other Accumulated Expenses was $2.0 million for Q1 2024 at Akso Health, up from $117.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.0 million in Q1 2024 and bottomed at $117.0 in Q1 2023.